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a  b  s  t  r  a  c  t
Objective:  We  previously  demonstrated  that Sirt1  regulates  apoptosis  in  cartilage  in vitro.  Here  we
attempt  to examine  in  vivo  cartilage  homeostasis,  using  Sirt1  total  body  knockout  (KO)  mice.
Method:  Articular  cartilage  was  harvested  from  hind  paws  of 1-week  and  3-week-old  mice  carrying  wild
type (WT)  or  null  Sirt1  gene.  Knees  of  Sirt1  haploinsufficient  mice  also  were  examined,  at  6 months.  Joint
cartilage  was  processed  for histologic  examination  or biochemical  analyses  of chondrocyte  cultures.
Results:  We  found  that  articular  cartilage  tissue  sections  from  Sirt1  KO  mice  up  to  3 weeks  of  age  exhibited
low  levels  of type 2  collagen,  aggrecan,  and  glycosaminoglycan  content.  In contrast,  protein  levels  of  MMP-
13  were  elevated  in the  Sirt1 KO  mice,  leading  to a potential  increase  of cartilage  breakdown,  already
shown  in the  heterozygous  mice.  Additional  results  showed  elevated  chondrocyte  apoptosis  in  Sirt1 KO
mice, as  compared  to  WT  controls.  In addition  to these  observations,  PTP1b  (protein  tyrosine  phosphatase
b)  was  elevated  in the  Sirt1  KO  mice,  in  line  with  previous  reports.
Conclusion:  The  findings  from  this  animal  model  demonstrated  that  Sirt1  KO  mice  presented  an altered
cartilage  phenotype,  with  an  elevated  apoptotic  process  and  a potential  degradative  cartilage  process.
Published by  Elsevier  Masson  SAS.
1. Introduction
Osteoarthritis (OA) is a complex and multifactorial degenera-
tive disease, leading to an imbalance between the catabolic and
anabolic factors in cartilage. Different mechanisms are involved,
such as inflammation, apoptosis, and breakdown of major extra-
cellular matrix components, such as aggrecan and, type 2 collagen
under the control of matrix metalloproteases, (MMPs), such as
aggrecanases and collagenases [1]. It has been well documented
that aging is a key risk factor in OA susceptibility [2,3]. In fact,
more than 50% of adults aged 65 or more reported an arthritis diag-
nosis, making OA one of the most common diseases in developed
countries [4].
Sirt1 has been shown to regulate lifespan and aging in simple
eukaryotes and in rodents [2,5,6]. In mammalians, Sirt1 has been
reported to play an important role in age-related diseases such as
osteoporosis, diabetes, and cancer [6–8]. Similarly, we have pre-
viously shown in vitro that Sirt1 modulates gene expression in
∗ Corresponding author. Tel.: +1 301 443 5406; fax: +1 301 480 2958.
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human osteoarthritic chondrocytes. Sirt1 positively regulates the
expression of extracellular matrix (ECM)-encoding genes of carti-
lage [9]. Further, Sirt1 enhances survival of human OA chondrocytes
by repressing apoptosis [10,11]. Recently, Sirt1 has been reported
to be involved in the pathogenesis of OA by modulating chondro-
cyte gene expression and hypertrophy [12]. Finally, Sirt1 plays an
anti-inflammatory role in different tissues by inhibiting the tran-
scription of pro-inflammatory-responsive genes [6].
Despite the growing evidence supporting in vitro studies
demonstrating Sirt1’s protective role in cartilage, few studies have
establish that these roles also exist in vivo. We  created Sirt1-null
mice [13,14] and found that – compared with normal mice – they
were smaller, had cranio-facial abnormalities, and their long bones
mineralized slower [15]. These observations were consistent with
the notion that Sirt1 may  play a role in cartilage development and
homeostasis. Additional observations of heterozygous Sirt1 mice
(Sirt1 +/−) showed that they exhibit increased apoptotic chondro-
cytes and OA severity with age, as compared to equivalent WT mice
[16].
In this study, we investigated articular cartilage of mice lacking
the Sirt1 protein (KO mice) and report that they were predis-
posed to develop OA because they present characteristic features of
1297-319X/$ – see front matter. Published by Elsevier Masson SAS.
doi:10.1016/j.jbspin.2013.01.001
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Fig. 1. Cartilage phenotype of Sirt1 KO mice. A. Sirt1 KO on the 129/J background mice. Photograph shows a KO mouse of approximately 2/3 normal size at 1 weeks of age,
with  closed eyes, obstructed fur and smaller joints compared to the WT.  B. At 2 days, before skeletal staining, the Sirt1 KO has already a smaller size. C. Skeletal staining with
alizarin red/alcian blue shows disparities in cartilage on the skull, on the rib cage, at the spine and on the big joints.
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Fig. 2. Skeletal staining with alizarin red/alcian blue, details: the arrows show a reduction in cartilage volume in the KO at each location, and a complete absence of cartilage
on  the calvariae. The skeletal staining shows a disorganization of the rib cages, a strong eye and joints cartilage defects.
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articular cartilage degeneration, even at a young age. Our results
showed an altered cartilage phenotype in these mice due to a higher




Experiments were performed on Sirt1-deleted 129/J mice aged
2 days, 7 days, and 3 weeks. Sirt1 knockout mice are indi-
cated as KO (total n = 9), and wild-type as WT  (total n = 20).
Littermates were generated from matings between the Sirt1+/− ani-
mals. In complement, Sirt1+/− animals were also examined at 6
months for histopathology and scored by the OA OARSI grading.
Genomic DNA from mice tail fragments was used for genotyp-
ing using the Extract-N-Amp Tissue PCR kit (Sigma, St Louis, MI).
PCR primer sequences designed to amplify the native Sirt1 and
the deleted Sirt1 were (Forward) 5′-TTCACATTGCATGTGTGTGTG-
3′ for both and (Reverse) 5′-TAGCCTGCGTAGTGTTGGTG-3′, and
5′-ATTTGGTAGGGACCCAAAGG-3′, respectively. All animals were
housed at Taconic, Maryland, under standard conditions of tem-
perature, light, food and water. All procedures were performed in
accordance with NIH Committees for Animal Use and Care (ARAC)
guidelines.
2.2. Primary mouse cell culture, cell count, and flow cytometry
Isolation of costal cartilage from KO, or WT  7-day-old mice,
and chondrocytes plating were adapted from Gabay et al. [17].
Briefly, pieces of costal cartilage were incubated in collagenase
3 mg/mL  for 1 h 30 min  at 37 ◦C, carefully isolated from soft tissue
in PBS, incubated in collagenase 0.5 mg/mL  overnight. Chondro-
cytes were washed, centrifuged and plated for a 7–10 day period
wherein they were allowed to propagate. Passages 0 and 1 chondro-
cytes were used for experiments because cartilage marker genes
maintained expression. Monolayer cultures were maintained in
culture conditions, as previously described [17], and growth
medium was  replaced every 3 days. Prior to analysis, cells were
rinsed with PBS, trypsinized with Trypsin 0.25%, resuspended in
10 ml  of growth medium, and counted with a hemocytometer using
trypan blue exclusion assay.
For analyses of cell death via flow cytometry, the cells were
rinsed once in chilled PBS, trypsinized, then resuspended in 10 ml of
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum. The cells were pelleted and resuspended in 100%
methanol. Cells were kept on ice for 10 min, pelleted, and treated
with RNase A (180 g; Sigma, St Louis, MI)  for 30 min  at room tem-
perature. Propidium iodide (Sigma, St Louis, MI)  was added to a
final concentration of 75 mg/ml. Cell cycle analysis was  performed
on a Coulter Profile 2 flow cytometer.
2.3. Protein extraction and immunoblotting
Whole-cell protein extracts were carried out according to Dvir-
Ginzberg et al., 2008 [9]. The protein extracts were resolved
by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(10 g protein/lane) and transferred onto PVDF membranes for
immunoblotting. The blots were processed as previously described
and probed with antibodies. Blots were developed using an alka-
line phosphatase-conjugated secondary antibody and developed
with BCIP/nitroblue tetrazolium solution (Invitogen, Camarillo,
CA). Antibodies were purchased from Abcam (Cambridge, MA)  for
PTP1b, MMP-13 and beta-actin, and Upstate/Millipore (Temecula,
CA) for Sirt1.
2.4. Histology and immunohistochemistry
For immunohistochemical analysis, cartilage samples were
fixed in 4% paraformaldehyde for 24 to 48 hours, dehydrated
in a graded series of ethanol baths, embedded in paraffin, and
cut into 5-m sections. Slides were rehydrated and incubated
Fig. 3. Articular cartilage from Sirt1 KO shows less aggrecan, type 2 collagen and glycosaminoglycan content than their WT littermates. The paws from each genotype were
processed for immunohistochemistry for either aggrecan, type 2 collagen, or alcian blue staining at 1 week. As shown in Fig. 3, alcian blue, aggrecan and type 2 collagen
staining intensity were abrogated in the Sirt1 KO at 1 week of age by 60%, 52% and 21% respectively (magnification ×10).
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with mouse anti-Aggrecan, mouse-anti-Type II Collagen (Mil-
lipore, Temecula, CA), mouse-anti-PTP1b (Abcam, Cambridge,
MA), or mouse anti-matrix metalloprotease- (anti–MMP-13,-
1,-3,ADAMTS-4,ADAMTS-5) Abcam, Cambridge, MA)  specific
antibodies and visualized using a broad-spectrum immunohis-
tochemistry kit (DAB, diaminobenzidine, Invitrogen, Camarillo,
CA).
To test the presence of glycosaminoglycans, sections were
stained with alcian blue and with safranin-O/light green to examine
subchondral bone and OA. Joints of the paws and the knees were
examined for 1 week and 3 week-old mice.
Cartilage defects at 6 months in the +/– were assessed in
accordance with the OsteoArthritis Research Society International
(OARSI) histopathology initiative-recommendations for histologi-
cal assessment of OA in mice [18].
Total skeletal coloration was performed with basic ethanol-
KOH:glycerol alizarin red-alcian blue, according to Depew [19].
Results were analyzed using the Color Atlas of Fetal Skeleton of
the mouse, rat and rabbit [20].
2.5. Statistical analysis
Means and standard deviations were calculated. Statistical anal-
ysis was performed using one-way analysis of variance, assuming
confidence levels of ≤ 95% (P ≤ 0.05) to be statistically significant.
Error bars represent the standard deviation around the mean value
of each data point. An asterisk (*) was  used to denote statistically
significant differences between controls and experimental condi-
tions. The immunoblots represent two repetitions of three different
experiments (n = 6). For IHC, the mean of positive stain cells was
determined; stained cells reflected a greater than 10-fold inten-
sity above the background, determined by scanning densitometry
(Image J software). A scoring method adapted from Lee et al., [21]
was used well to determine the coloration of the tissue matrix. An
average of three fields from three sections of each separate geno-
type (–/–, ++) of three different animals were assessed. Each field
was blindly read by two  different readers. Cartilage defects were
scored in accordance with the OARSI histopathology initiative OA
scoring for mice [18].
Fig. 4. Elevated protein levels of MMP-13 in Sirt1 KO cartilage at 3 weeks. The paws of 3-week-old mice were processed for immunohistochemistry for MMP-13, and
counterstained with hematoxylin (magnification ×10 upper panel and ×20 lower panel). The percent positively stained cells per field were determined for an average of
six  fields from three sections of three separate mice of each genotype (graph below immunosections). The error bars in all graphs indicate the standard deviation and the
statistical significance is indicated by an asterisk, *. P < 0.001 (=1.7189E-5).
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3. Results
3.1. Sirt1 KO mice exhibited defects in the cartilage of the skull,
spine, rib cages, and joints, consistent with their reduced size
Examination of the two strains shows a reduced size for the
Sirt1 KO mice, as compared to the wild types, at 2, 7 days and 3
weeks. Some exterior defects are also evident, such as closed eyes
and bad fur at 1 week (Fig. 1). At 2 days, the mice already exhibit a
difference in size (Fig. 1B). Skeletal staining at 2 days on the Sirt-1
KO and Sirt1 Wild type mice (Fig. 1C), confirmed that Sirt1 KO mice
exhibit a smaller size, cranio-facial and eye defects compared to
their littermate, in line with previous reports [13,15].
We further examined the effect on the skeleton and cartilage
on the same mice (Fig. 2). Sirt1 KO mice exhibited less cartilage
in the skull, rib cage, spine and in knee joints, due to their size.
They all exhibited less bone mineralization which implies defects in
cartilage hypertrophy attributing to delayed skeletal development.
Interestingly, the sutures of the calvariae were not fixed in the KO,
compared with the WT  mice (arrows). These observations were
similar in all KO analyzed, as compared with the WT  mates (n = 3
each).
3.2. Articular cartilage tissue from Sirt1 KO exhibited low levels of
type 2 Collagen, Aggrecan and Glycosaminoglycan (GAG) content
in the paws, and a high level of MMP-13
The superficial zone from articular cartilage of distal interpha-
langian joints of the posterior paws, were examined. Alcian blue
coloration was carried out to visualize glycosaminoglycan (GAG)
content, which are hallmarks of healthy cartilage. Results, illus-
trated in Fig. 3, showed less GAG content in KO paws as compared
to WT.  To further assess levels of aggrecan and type 2 Collagen,
immunohistochemistry for cartilage was carried out and quanti-
fied using densitometry and statistical analysis. Overall, the paws
showed a decrease in alcian blue intensity, aggrecan, and type 2
collagen in the KO (60%, 52%, and 21%, respectively) as compared
to WT  mice at 1 week of age.
To determine whether the catalytic enzymes involved in car-
tilage degeneration were elevated in the KO mice, we  performed
immunohistochemistry for matrix metalloproteinase (MMP)  -13,
aggrecanase, which have been documented to be elevated in OA
[22]. As shown in Fig. 4, this MMP  is increased in the cartilage of
the KO mice, compared with their littermates. Immunostaining for
MMP-1, MMP-3, ADAMTS-4, and -5 was  similar between KO and
WT at 3 weeks of age (data not shown).
Because KnockOut mice die in early age, additional analyses and
scoring were carried out in accordance with the OARSI initiative OA
scoring for adult mice in the heterozygous mice (Fig. 5) The Sirt1+/−
mice presented elevated cartilage degeneration at 6 months, with
a total mean score of 3.9, corresponding to moderate OA relative to
their WT littermates which possessed a score of 1.25 corresponding
to early-stage OA.
3.3. Enhanced apoptosis in cartilage of Sirt1 KO compared to WT
mice; PTP1b is elevated in Sirt1 KO mice cartilage compared with
WT mice
Mice chondrocytes from each genotype were cultured and
counted daily. Whereas WT  chondrocytes grew normally,
Fig. 5. Elevated cartilage breakdown in older Sirt1 heterozygous mice. Knee sections of 6-month-old WT and Sirt1 heterozygous mice were processed for coloration with
safranin-O/Light green. Examination of 36 sections from 6 months mice knees showed significant higher cartilage degradation in the Sirt1 heterozygous as compared with
their  littermates (magnification ×16). The pictures are representative of the whole analysis. At 6 months, the mean of the cartilage degradation grade, adapted from the OARSI
semi-quantitative scoring for OA severity (here, grade 0 = no degradation, grade 5 = denuded cartilage surface with sclerotic bone) showed 3.9 for the Sirt1 heterozygous and
1.2  for the WT (P < 0.001). The scoring of 12 samples for each genotype (two sections of two different knees from three different mice from each genotype) showed more
severe  grades for the Sirt1 heterozygous knees.
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Fig. 6. Increased apoptotic process in Sirt1 KO vs. WT.  A. Two  different genotypes chondrocytes were plated at 500,000 cells/plate. Student T-test compared the WT and KO
(48  h: P = 5.285 E-09, P < 0.0001; 72 h: P = 6.122 E-07, P < 0.0001; 96 h: P = 3.0066 E-07, P < 0.0001; 7 days: P = 2.5 E-05, P < 0.0001 respectively). B. Flow cytometry was carried
out  for apoptotic cells using the propidium iodide method. The graph represents the apoptotic cells percentage found after 48 h or 4 days of culture. WT and KO exhibited
significant differences at 48 h and 4D (P = 8.08 E-06, P < 0.0001 et P = 6.99 E-05, P < 0.0001 respectively). C. Protein extracts from KO and WT genotypes were immunoblotted
for  PTP1b antibody. The graph represents the ratio PTP1b/beta-actin, by image J scanning densitometry (P < 0.001). The error bars in all graphs indicate the standard deviation,
and  the statistical significance as indicated by an asterisk, *.
articular chondrocytes derived from the Sirt1 KO mice did not prop-
agate in culture (Fig. 6A). FACS analyses indicated elevated numbers
of apoptotic cells in cultures of KO chondrocytes at 2 and 4 days
(Fig. 6B). This data supports that Sirt1 contributes to chondrocyte
proliferation and lack of it could lead to limited growth and devel-
opment of cartilage.
As previously published by Gagarina et al. in 2010, Sirt1 may
prevent chondrocyte apoptosis in a protein tyrosine phosphatase b
(PTP1b)-dependent manner. To examine PTP1b expression in vivo,
immunoblot analyses were carried out. Immunoblot analyses of
proteins derived from the different genotypes confirmed that
PTP1b was elevated in Sirt1 KO mice compared with WT  controls
(Fig. 6C), further supporting the enhanced levels of apoptotic chon-
drocytes in KO mice.
4. Discussion
Recent publications show that the protein deacetylase Sirt1
plays an important role in cartilage biology and homeostasis
[9,10,15,23,24]. Our current study demonstrates that mice lacking
Sirt1 protein possess an altered cartilage phenotype, in line with
our previous reports in 9 month Sirt1 haploinsufficient mice [16].
Further, we describe two different phenomena underlying this phe-
notype: an increase in chondrocyte apoptosis and an accelerated
articular cartilage breakdown showing a regulation of cartilage by
Sirt1 in vivo.
The Sirt1-null mice were smaller in size compared to WT  mice
in equivalent ages, which agrees with previous reports [13,14,25].
We also found obvious defects on the skin that could benefit further
investigation. These mice suffer high perinatal mortality, partic-
ularly when carried on an inbred mouse strain. Indeed, in vitro
analyses showed that chondrocytes isolated from pups surviving 7
days after birth, did not attach properly, frequently apoptosed, and
were found floating in culture growth media. Here we  conclude
that much of the age-related cartilage phenotype is attributed to
Sirt1protein.
We also compared histologic data for the WT  and Sirt1 heterozy-
gous strains at 6 months presented Fig. 5, because the KO mice
were not alive at this age. As seen in the pictures, heterozygous
mice possess a significant enhancement in OA severity and cartilage
degradation as compared to WT  mice at 6 months.
We previously showed that Sirt1 enhances the survival of
human osteoarthritic chondrocytes by repressing protein tyrosine
phosphatase 1b and activating the insulin-like growth factor recep-
tor pathway [10,15]. Consistent reports show that using Sirtuin
inhibitors for Sirt1 and Sirt2 induced cell death through p53 hyper-
acetylated [26]. Accordingly, and in line with our current report,
altering Sirt1 levels could lead to enhanced cell death via multi-
ple mechanisms and diminish the protective effect Sir11 holds on
chondrocyte viability in vivo.
Very few studies have demonstrated the role of Sirt1 in vivo with
regards to cartilage biology or age-induced arthritis. As mentioned,
our recent publication comparing WT  and haploinsufficient Sirt1
mice compared musculoskeletal features, OA severity scoring, and
apoptosis in cartilage of 1-month-old and 9-month-old mice [16].
The results showed a significant decrease in Sirt1 protein levels in
the heterozygous mice compared with their littermates at 1 month.
Interestingly, both strains ceased to express full-length Sirt1 at 9
months.
Sirt1 KO mice showed an accelerated cartilage degenerative
process and early onset OA features. Accumulation of matrix met-
alloproteinases in the cartilage and low levels of type 2 collagen
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and aggrecan could predict very weak mechanical properties of
cartilage in these mice, making them susceptible to cartilage degen-
eration. Our study showed increased MMP-13, aggrecanase, with
reduced ECM content in the KO mice at 3 weeks of age. However, it
is not yet clear if the decreased intensity of aggrecan, type 2 collagen
and GAG content in our experiments is due to the decrease of the
cellularity within cartilage tissues of KO mice. These data suggest
early OA onset exists in KO mice. While MMP-13 levels are elevated
in Sirt1 KO mice, other aggrecanases did show a similar increase in
these mice strains. It appears that collagen type 2 breakdown and
MMP-13 were most affected and correlated well with OA severity
in Sirt1 in vivo mice model used herein.
The present communication further accentuates that Sirt1 is
necessary for the normal development of articular cartilage in vivo.
In its absence, even at a young age, mice develop cartilage degen-
eration and early-onset OA, which is normally developed with
advanced age.
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